NDC 50844-197 - Aspirin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50844-197
- Package NDCs from labels
- 50844-197-12
- Manufacturer
- L.N.K. International, Inc. | LNK International, Inc.
- Effective date
- 2019-08-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Quality Plus 44-157-NI-Delisted | L.N.K. International, Inc. | LNK International, Inc. | 2019-08-14 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walgreen Company | 5dcc2b01-6556-46bc-a451-f09dd0bd1eed | 2025-09-04 | Warnings | R16CO5Y76E |
| Effervescent Orange Cold Relief | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | CVS Pharmacy, Inc. | 4bb70a55-de44-3dc1-e054-00144ff8d46c | 2025-09-04 | Warnings | R16CO5Y76E |
| Equaline migraine formula | ACETAMINOPHEN, ASPIRIN, CAFFEINE | United Natural Foods, Inc. dba UNFI | 28ab87e5-6b7d-4737-95e8-4f842ecd9408 | 2025-08-28 | Warnings | R16CO5Y76E |
| Aspirin Enteric Coated Low Dose | ASPIRIN | Walgreen Company | b11a4c4e-374c-403e-a757-5e9700f9f03b | 2025-08-27 | Warnings | R16CO5Y76E |
| good neighbor pharmacy migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amerisource Bergen | 201f101a-3b53-4349-896c-6b86cdd9b831 | 2025-08-26 | Warnings | R16CO5Y76E |
| Aspirin Low Dose Safety Coated | ASPIRIN | BJWC (Berkley & Jensen / BJ's) | 577035a5-88ab-431c-8598-7a19dd633fe9 | 2025-08-26 | Warnings | R16CO5Y76E |
| Low Dose Aspirin | ASPIRIN | BJWC (Berkley & Jensen / BJ's) | 2f32b096-d29a-c7c7-e063-6294a90a2bbe | 2025-08-22 | Warnings | R16CO5Y76E |
| Medique Medi Seltzer | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Unifirst First Aid Corporation | 528da9d9-2a52-4c16-b7b2-61b3eee1abea | 2025-08-19 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | CHAIN DRUG MARKETING ASSOCIATION INC | 4005f8dd-3050-4590-8703-6997444e8df3 | 2025-08-13 | Warnings | R16CO5Y76E |
| good sense headache relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | L. Perrigo Company | 4cae0580-7ee3-4f38-8d13-79c7d7615f8f | 2025-08-12 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | PROSTAT FIRST AID | 3bdb9d89-9000-69f9-e063-6294a90a0c97 | 2025-08-08 | Warnings | R16CO5Y76E |
| Systane COMPLETE | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 2df0de02-a3e2-471a-9e10-040c3fba75fe | 2025-08-08 | Warnings | 6DC9Q167V3 |
| Aspi-Cor | ASPIRIN | L.N.K. International, Inc. | 9f919a48-ffd8-49fa-b6fd-ec71cc12e64b | 2025-08-08 | Warnings | R16CO5Y76E |
| Aspirin Low Dose | ASPIRIN | A-S Medication Solutions | 8575ef9d-2eae-412a-a252-82b03f4d5275 | 2025-08-08 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | A-S Medication Solutions | 7a91b1df-8d6d-4205-9822-bc4d800555f7 | 2025-08-08 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | A-S Medication Solutions | 44b8c203-37c5-425e-9110-f7eb614f9c2d | 2025-08-08 | Warnings | R16CO5Y76E |
| Systane Balance | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | c7b1a03a-a5f2-409e-a34a-d6f166671de5 | 2025-08-07 | Warnings | 6DC9Q167V3 |
| Low Dose Aspirin | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | c46688ec-e976-4f76-9265-645f59970ff5 | 2025-08-06 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | P & L Development, LLC | c54ad829-f2e8-4367-b439-af20b0ef8ad2 | 2025-08-06 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Marlex Pharmaceuticals Inc. | cc7013ea-cf30-6f59-e053-2a95a90a1148 | 2025-08-05 | Warnings | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.